SEC Form 4 · accession 0001179110-15-003035
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 3:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2015 | A | 18,862 | $0.00 | A | 127,367 | D | |
| Common Stock | Feb 18, 2015 | S | 252 | $11.91 | D | 127,115 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.02 | Feb 18, 2015 | A | 37,725 | A | May 18, 2015 | Feb 18, 2025 | Common Stock | 37,725 | 223,671 | D |
Explanation of responses
- F1Represents 18,862 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Bishop. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2016 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
- F2Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date.
- F3This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9 2009.